… according to various neuropsychiatric symptoms across a range of clinical small vessel
disease populations. Our study broadens understanding of small vessel disease, which is often …

… study were aged 55 to 91 years and had undergone MRI to identify whether they had cerebral
small vessel diseases … CAA primarily affects cortical vessels by the deposition of amyloid-β …

… Cerebral small vessel disease (SVD) and neuropsychiatric symptoms (NPS) independently
… studies could examine the influence of other AD biomarkers such as amyloid or tau burden. …

… attempt to disentangle whether neuropsychiatric symptoms are … -hit of small vessel dysfunction
and β-amyloid accumulation … with higher SVD burden, including vascular populations that …

… : Neuropsychiatric symptoms are related to disease progression and cognitive decline over
time in cerebral small vessel disease (… We investigated neuropsychiatric symptoms and their …

… to characterize and investigate the consequences of CAA-related small vessel disease (SVD)
damage unambiguously from the destructive effect of large intracerebral bleeds. …

… Background: Cerebral small vessel disease (SVD) and Alzheimer’s disease pathology,
namely amyloid-(A) deposition, commonly co-occur. Exactly how they interact remains uncertain. …

… The burden of small-vessel disease in our sample was likely low based on the study criteria
… with greater vascular disease burden. We used visual rating scale scores to designate …

… between higher neuropsychiatric symptoms and lower level … was independent of baseline
amyloid burden or WMH volume. … PET amyloid burden or small vessel cerebrovascular disease…

… , or amyloid pathologies were not examined. Future well-designed studies are warranted
to examine the interaction between cerebral small and large vessel diseases, and amyloid …